Tag Archives: RheumaGen

BIOTECH

RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases

Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401,...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.